Stay updated on Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial
Sign up to get notified when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.

Latest updates to the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a site revision to v3.4.2, and a previously displayed government funding status notice has been removed. These are maintenance-related updates that do not affect the study details or how users interact with the page.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site version from v3.4.0 to v3.4.1, with no changes to study data, eligibility criteria, or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary and new metadata fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) with an updated revision label to v3.4.0. Removed several estimated or legacy metadata items (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the older revision label.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.4' and removed the previous entry 'Revision: v3.3.3' in the page's revision history.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study's location listings were updated, adding new sites across several U.S. states and in Spain (Galicia and Santa Cruz de Tenerife). The page also removed some previously listed location blocks, reflecting a revision to the site deployment (transition to revision 3.3.3).SummaryDifference0.8%

- Check92 days agoChange DetectedRevision metadata updated: added v3.3.2 and removed v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.